This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Karch SB, editor. Drug Abuse Handbook. 2nd ed. Boca Raton: CRC Press; 2006.KarchSBeditor2nd edBoca RatonCRC Press200610.1201/9781420003468Search in Google Scholar
Foster DJ, Somogyi AA, Bochner F. Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4. Br J Clin Pharmacol 1999; 47 : 403 – 12. doi: 10.1046/j.1365-2125.1999.00921.xFosterDJSomogyiAABochnerF. MethadoneN-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A419994740312doi10.1046/j.1365-2125.1999.00921.x201423110233205Open DOISearch in Google Scholar
Totah RA, Allen KE, Sheffels P, Whittington D, Kharasch ED. Enantiomeric metabolic interactions and stereoselective human methadone metabolism. J Pharmacol Exp Ther 2007;321:389–99. doi: 10.1124/jpet.106.117580TotahRAAllenKESheffelsPWhittingtonDKharaschEDEnantiomeric metabolic interactions and stereoselective human methadone metabolism200732138999doi10.1124/jpet.106.11758017259447Open DOISearch in Google Scholar
Yongfang Li, Kantelip JP, Gerritsen-van Schieveen P, Davani S. Interindividual variability of methadone response: impact of genetic polymorphism. Mol Diagn Ther 2008;12:109–24. doi: 10.1007/BF03256276YongfangLiKantelipJPGerritsen-van SchieveenPDavaniSInterindividual variability of methadone response: impact of genetic polymorphism20081210924doi10.1007/BF0325627618422375Open DOISearch in Google Scholar
Coller JK, Barratt DT, Dahlen K, Loennechen MH, Somogyi AA. ABCB1 genetic variability and methadone dosage requirements in opioid- dependent individuals. Clin Pharmacol Ther 2006;80:682–90. doi: 10.1016/j. clpt.2006.09.011CollerJKBarrattDTDahlenKLoennechenMHSomogyiAA.ABCB1 genetic variability and methadone dosage requirements in opioid- dependent individuals20068068290doi10.1016/j.clpt.2006.09.01117178268Open DOISearch in Google Scholar
Richards-Waugh LL, Primerano DA, Dementieva Y, Kraner JC, Rankin GO. Fatal methadone toxicity: potential role of CYP3A4 genetic polymorphism. J Anal Toxicol 2014;38:541–7. doi: 10.1093/jat/bku091Richards-WaughLLPrimeranoDADementievaYKranerJCRankinGOFatal methadone toxicity: potential role of CYP3A4 genetic polymorphism2014385417doi10.1093/jat/bku091422988825217544Open DOISearch in Google Scholar
Sutlovic D, Kljucevic Z, Sliskovic L, Susnjar H, Viskovic I, Definis-Gojanovic M. Methadone maintenance treatment: a 15-year retrospective study in Split-Dalmatia County, Croatia. Ther Drug Monit 2018;40:486–94. doi: 10.1097/FTD.0000000000000519SutlovicDKljucevicZSliskovicLSusnjarHViskovicIDefinis-GojanovicMMethadone maintenance treatment: a 15-year retrospective study in Split-Dalmatia County, Croatia20184048694doi10.1097/FTD.000000000000051929649094Open DOISearch in Google Scholar
Ključević Z, Benzon B, Ključević N, Veršić Bratinčević M, Sutlović D. Liver damage indices as a tool for modifying methadone maintenance treatment: a cross-sectional study. Croat Med J 2018;59:298–306. doi: 10.3325/cmj.2018.59.298KljučevićZBenzonBKljučevićNVeršić BratinčevićMSutlovićDLiver damage indices as a tool for modifying methadone maintenance treatment: a cross-sectional study201859298306doi10.3325/cmj.2018.59.298Open DOISearch in Google Scholar
Bogdanović Z, Marinović-Terzić I, Kuret S, Jerončić A, Bradarić N, Forempoher G, Polašek O, Anđelinović Š, Terzić J. The impact of IL-6 and IL-28B genepolymorphisms on treatment outcome ofchronic hepatitis C infection amongintravenous drug users in Croatia. PeerJ 2016;4:e2576. doi: 10.7717/peerj.2576BogdanovićZMarinović-TerzićIKuretSJerončićABradarićNForempoherGPolašekOAnđelinovićŠTerzićJThe impact of IL-6 and IL-28B genepolymorphisms on treatment outcome ofchronic hepatitis C infection amongintravenous drug users in Croatia20164e2576doi10.7717/peerj.2576508858227812403Open DOISearch in Google Scholar
Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Sulkowski MS, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43:1317–25. doi: 10.1002/hep.21178SterlingRKLissenEClumeckNSolaRCorreaMCMontanerJSulkowskiMSTorrianiFJDieterichDTThomasDLMessingerDNelsonMDevelopment of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection200643131725doi10.1002/hep.2117816729309Open DOISearch in Google Scholar
Veršić Bratinčević M, Visković T, Sutlović D. Comparison of the solid phase and liquid-liquid extraction methods for methadone determination in human serum and whole blood samples using gas chromatography/mass spectrometry. Arh Hig Rada Toksikol 2017;68:308–14. doi: 10.1515/aiht-2017-68-2953Veršić BratinčevićMViskovićTSutlovićDComparison of the solid phase and liquid-liquid extraction methods for methadone determination in human serum and whole blood samples using gas chromatography/mass spectrometry20176830814doi10.1515/aiht-2017-68-295329337687Open DOISearch in Google Scholar
Laboratory of Immunogenomics and Immunoproteomics. Files [displayed 26 August 2020]. Available at http://www.dr-petrek.eu/documents/HWE.xlsAvailable athttp://www.dr-petrek.eu/documents/HWE.xlsSearch in Google Scholar
Totah RA, Sheffels P, Roberts T, Whittington D, Thummel K, Kharasch ED. Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology 2008;108:363–74. doi: 10.1097/ALN.0b013e3181642938TotahRASheffelsPRobertsTWhittingtonDThummelKKharaschEDRole of CYP2B6 in stereoselective human methadone metabolism200810836374doi10.1097/ALN.0b013e318164293818292673Open DOISearch in Google Scholar
Ahmad T, Sabet S, Primerano DA, Richards-Waugh LL, Rankin G. Tell-tale SNPs: The role of CYP2B6 in methadone fatalities. J Anal Toxicol 2017;41:325–33. doi: 10.1093/jat/bkw135AhmadTSabetSPrimeranoDARichards-WaughLLRankinGTell-tale SNPs: The role of CYP2B6 in methadone fatalities20174132533doi10.1093/jat/bkw135541202528184434Open DOISearch in Google Scholar
Dennis BB, Bawor M, Thabane L, Sohani Z, Samaan Z. Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: A systematic review and meta-analysis. PLoS One 2014;9(1):e86114. doi: 10.1371/journal.pone.0086114DennisBBBaworMThabaneLSohaniZSamaanZImpact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: A systematic review and meta-analysis201491e86114doi10.1371/journal.pone.0086114390602824489693Open DOISearch in Google Scholar
Wu SL, Wang SC, Tsou HH, Kuo HW, Ho IK, Liu SW, Hsu Y-T, Chang Y-S, Liu Y-L. Hepatitis C virus infection influences the S-methadone metabolite plasma concentration. PloS One 2013;8(7):e69310. doi: 10.1371/journal. pone.0069310WuSLWangSCTsouHHKuoHWHoIKLiuSWHsuY-TChangY-SLiuY-LHepatitis C virus infection influences the S-methadone metabolite plasma concentration201387e69310doi10.1371/journal.pone.0069310372061923935979Open DOISearch in Google Scholar
Fonseca F, de la Torre, Diaz L, Pastor A, Cuyàs E, Pizarro N, Khymenets O, Farré M, Torrens M. Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response. PloS One 2011;12:e19527. doi: 10.1371/journal. pone.0019527FonsecaFde laTorreDiazLPastorACuyàsEPizarroNKhymenetsOFarréMTorrensMContribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response201112e19527doi10.1371/journal.pone.0019527309339221589866Open DOISearch in Google Scholar